Literature DB >> 34362205

Ocular Complications of Obstructive Sleep Apnea.

Pei-Kang Liu1,2,3,4, Tzu-Yu Chiu1,2, Nan-Kai Wang4, Sarah R Levi4, Ming-Ju Tsai5,6,7,8.   

Abstract

Obstructive sleep apnea (OSA), the most common form of sleep-disordered breathing, is characterized by repetitive episodes of paused breathing during sleep, which in turn induces transient nocturnal hypoxia and hypercapnia. The high prevalence of OSA and its associated health consequences place a heavy burden on the healthcare system. In particular, the consequent episodic oxygenic desaturation/reoxygenation series and arousals from sleep in patients with OSA have the potential to trigger oxidative stress, elevated systemic inflammatory responses, and autonomic dysfunction with sympathetic activation. Given these adverse side-effects, OSA is highly correlated to many eye diseases that are common in everyday ophthalmic practices. Some of these ocular consequences are reversible, but they may permanently threaten a patient's vision if not treated appropriately. Here, this article seeks to review the ocular consequences and potential pathophysiologic associations in patients with OSA. Understanding these OSA-related eye diseases may help clinicians provide comprehensive care to their patients.

Entities:  

Keywords:  complications; eye; inflammation; nocturnal hypoxia; obstructive sleep apnea; oxidative stress; sleep-disordered breathing; sympathetic activation

Year:  2021        PMID: 34362205     DOI: 10.3390/jcm10153422

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  2 in total

1.  Assessment of the Effectiveness of Obstructive Sleep Apnea Treatment Using Optical Coherence Tomography to Evaluate Retinal Findings.

Authors:  Gloria Tejero-Garcés; Francisco J Ascaso; Paula Casas; Maria I Adiego; Peter Baptista; Carlos O'Connor-Reina; Eugenio Vicente; Guillermo Plaza
Journal:  J Clin Med       Date:  2022-02-03       Impact factor: 4.241

2.  Commentary: Obstructive sleep apnoea as a risk factor for glaucoma.

Authors:  Geeta Behera; Subashini Kaliaperumal
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.